1. Neuronal Signaling Stem Cell/Wnt
  2. γ-secretase Amyloid-β
  3. BIIB042

BIIB042 is a potent, orally active, brain-penetrant, and selective γ-secretase modulator (GSM). BIIB042 reduces Aβ42 and increases Aβ38 levels in cells. BIIB042 significantly reduces brain Aβ42 levels in CF-1 mice and Fischer rats, as well as plasma Aβ42 levels in cynomolgus monkeys. BIIB042 reduces Aβ42 levels and Aβ plaque burden in Tg2576 mice. BIIB042 can be used for alzheimer's disease (AD) research[1][2].

For research use only. We do not sell to patients.

BIIB042

BIIB042 Chemical Structure

CAS No. : 1257396-73-8

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of BIIB042:

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

BIIB042 is a potent, orally active, brain-penetrant, and selective γ-secretase modulator (GSM). BIIB042 reduces Aβ42 and increases Aβ38 levels in cells. BIIB042 significantly reduces brain Aβ42 levels in CF-1 mice and Fischer rats, as well as plasma Aβ42 levels in cynomolgus monkeys. BIIB042 reduces Aβ42 levels and Aβ plaque burden in Tg2576 mice. BIIB042 can be used for alzheimer's disease (AD) research[1][2].

In Vitro

BIIB042 (compound 10a) inhibits COX1 and COX2 very weakly (IC50 = 35 and 27 μM, respectively) and exhibits weak inhibition of the hERG channel (IC50 = 15 μM)[1].
BIIB042 exhibits good cellular permeability and is not a substrate for efflux transporters[1].
BIIB042 demonstrates good metabolic stability in liver microsomes and does not inhibit major cytochrome P450 enzymes[1].
BIIB042 (3-30 μM, 20 h) has no effect on HES-1 protein levels in MC-IXC cells, indicating its selective action on amyloid precursor protein processing without impacting Notch signaling[2].
BIIB042 (20 h) reduces the levels of Aβ42 (IC50 = 64.3 nM), increased the levels of Aβ38 (EC50 = 146 nM) and has little effect on the levels of Aβ40 in H4-APP cells[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[2]

Cell Line: MC-IXC cells
Concentration: 3, 10 and 30 μM
Incubation Time: 20 h
Result: Did not alter HES1 protein levels.
In Vivo

BIIB042 (0-60 mg/kg, p.o. (in diet), daily for 65 days) significantly increases Aβ38 levels and decreases Aβ42 levels in brain of Tg2576 mice[2].
BIIB042 (0.3-30 mg/kg, p.o. (in diet), daily for 6 months) significantly decreases Aβ42 levels in brain, and reduces parenchymal amyloid plaque burden of Tg2576 mice[2].
BIIB042 (0-100 mg/kg, i.g., single dose) dose-dependently lowers Aβ42 and elevates Aβ38 in the brain and plasma of CF-1 mice, demonstrating a potent and brain-penetrant GSM profile[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Tg2576 mice (5 months old)[2]
Dosage: 0, 3, 10, 30 and 60 mg/kg
Administration: p.o. (in diet), daily for 65 days
Result: Significantly increased Aβ38 levels in brain in a dose-dependent manner.
Significantly decreased Aβ42 levels in brain in a dose-dependent manner.
Showed no significant changes in levels of Aβ40.
Significantly reduced insoluble Aβ42 at 10, 30 and 60 mg/kg compared to vehicle.
Showed no significant changes in insoluble Aβ38.
Animal Model: Tg2576 mice (10 months old)[2]
Dosage: 0.3,1,10 and 30 mg/kg
Administration: p.o. (in diet), daily for 6 months
Result: Significantly reduced soluble and insoluble Aβ42 levels in the brain and plasma at 30 mg/kg.
Significantly reduced parenchymal amyloid plaque burden in both the cortex and hippocampus at 30 mg/kg.
Showed a trend towards increased Aβ levels at 0.3 and 1 mg/kg.
Animal Model: CF-1 mice[2]
Dosage: 0, 3, 10, 30 and 100 mg/kg
Administration: i.g., single dose
Result: Induced significant and dose-dependent decreases in Aβ42 at all tested doses.
Showed a dose-dependent increases in Aβ38 at 10, 30 and 100 mg/kg.
Induced Aβ pharmacodynamic responses in plasma, with similar effects as in brain with decreases in Aβ42, increases in Aβ38 and small changes in Aβ40 at higher doses.
Brain concentrations were approximately 80% of plasma concentrations at the 4 h time point across all doses.
Molecular Weight

499.54

Formula

C29H29F4NO2

CAS No.
SMILES

OC([C@H](C)C(C=C1)=CC(C2=CC=C(C(F)(F)F)C=C2)=C1[C@H](N3CCC(C)CC3)C4=CC=C(F)C=C4)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
BIIB042
Cat. No.:
HY-103537A
Quantity:
MCE Japan Authorized Agent: